|
A549
|
IC50 |
0.009 3
Compound: 3; FL118
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 38092421]
|
|
2008
|
IC50 |
37.28 1
Compound: 4; FL118
|
Antiproliferative activity against human 2008 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human 2008 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
2008
|
IC50 |
37.28 1
Compound: 4; FL118
|
Antiproliferative activity against human 2008 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human 2008 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
A549
|
IC50 |
0.083 3
Compound: 24; FL118, Table 2, cpd 7
|
Cytotoxicity against human A549 cells incubated for 48 hrs by by SpectraMax M5 microplate reader analysis
Cytotoxicity against human A549 cells incubated for 48 hrs by by SpectraMax M5 microplate reader analysis
|
[PMID: 34175539]
|
|
A549
|
IC50 |
0.083 3
Compound: 24; FL118, Table 2, cpd 7
|
Cytotoxicity against human A549 cells incubated for 48 hrs by by SpectraMax M5 microplate reader analysis
Cytotoxicity against human A549 cells incubated for 48 hrs by by SpectraMax M5 microplate reader analysis
|
[PMID: 34175539]
|
|
A549
|
EC50 |
0.86 1
Compound: 11; FL118
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 38421819]
|
|
SW-620
|
IC50 |
0.93 1
Compound: 4; FL118
|
Antiproliferative activity against human SW-620 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human SW-620 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
A549
|
IC50 |
0.009 3
Compound: 3; FL118
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability by MTT assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability by MTT assay
|
[PMID: 38092421]
|
|
Bel-7402
|
IC50 |
21.75 1
Compound: 4; FL118
|
Antiproliferative activity against human Bel-7402 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human Bel-7402 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
A549
|
IC50 |
0.083 3
Compound: 24; FL118, Table 2, cpd 7
|
Cytotoxicity against human A549 cells incubated for 48 hrs by by SpectraMax M5 microplate reader analysis
Cytotoxicity against human A549 cells incubated for 48 hrs by by SpectraMax M5 microplate reader analysis
|
[PMID: 34175539]
|
|
NSCLC
|
EC50 |
1 1
Compound: 24; FL118, Table 2, cpd 7
|
Cytotoxicity against human NSCLC cells
Cytotoxicity against human NSCLC cells
|
[PMID: 34175539]
|
|
H69AR
|
IC50 |
6.29 1
Compound: 4; FL118
|
Antiproliferative activity against human NCI-H69AR cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human NCI-H69AR cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
HepG2
|
IC50 |
10.64 1
Compound: 4; FL118
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
A549
|
IC50 |
43 14
Compound: 11; FL118
|
Cytotoxicity against human A549 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 38421819]
|
|
EKVX
|
IC50 |
0.006 3
Compound: 3; FL118
|
Antiproliferative activity against human EKVX cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Antiproliferative activity against human EKVX cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 38092421]
|
|
A549
|
IC50 |
|
Growth inhibition of human A549 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
Growth inhibition of human A549 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
|
[PMID: 38100041]
|
|
HCT-116
|
IC50 |
0.005 3
Compound: 3; FL118
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 38092421]
|
|
HL-60
|
IC50 |
|
Inhibition of Topoisomerase I by cleavage complex formation in human HL-60 cells
Inhibition of Topoisomerase I by cleavage complex formation in human HL-60 cells
|
[PMID: 8410981]
|
|
H69AR
|
IC50 |
6.29 1
Compound: 4; FL118
|
Antiproliferative activity against human NCI-H69AR cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human NCI-H69AR cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
MCF7
|
IC50 |
63.26 1
Compound: 4; FL118
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
Bel-7402
|
IC50 |
21.75 1
Compound: 4; FL118
|
Antiproliferative activity against human Bel-7402 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human Bel-7402 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NCI-H446
|
IC50 |
6.61 1
Compound: 4; FL118
|
Antiproliferative activity against etoposide/cisplatin combination-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against etoposide/cisplatin combination-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NCI-H446
|
IC50 |
18.54 1
Compound: 4; FL118
|
Antiproliferative activity against Irinotecan-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against Irinotecan-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
EKVX
|
IC50 |
0.006 3
Compound: 3; FL118
|
Antiproliferative activity against human EKVX cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
Antiproliferative activity against human EKVX cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay
|
[PMID: 38092421]
|
|
HCT-8
|
IC50 |
0.005 3
Compound: 3; FL118
|
Antiproliferative activity against human HCT-8 cells assessed as inhibition of cell growth
Antiproliferative activity against human HCT-8 cells assessed as inhibition of cell growth
|
[PMID: 38092421]
|
|
NCI-H446
|
IC50 |
6.61 1
Compound: 4; FL118
|
Antiproliferative activity against etoposide/cisplatin combination-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against etoposide/cisplatin combination-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
PC-3
|
IC50 |
8.1 1
Compound: Methylenedioxy Camptothecin (table 1)
|
Concentration required to inhibit growth of human prostate PC-3 carcinoma cell line
Concentration required to inhibit growth of human prostate PC-3 carcinoma cell line
|
[PMID: 15454230]
|
|
NCI-H446
|
IC50 |
8.87 1
Compound: 4; FL118
|
Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NCI-H69
|
IC50 |
15.81 1
Compound: 4; FL118
|
Antiproliferative activity against human NCI-H69 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human NCI-H69 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NCI-H446
|
IC50 |
8.87 1
Compound: 4; FL118
|
Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
HeLa
|
IC50 |
9.6 1
Compound: Methylenedioxy Camptothecin (table 1)
|
Concentration required to inhibit growth of human cervical HeLa carcinoma cell line
Concentration required to inhibit growth of human cervical HeLa carcinoma cell line
|
[PMID: 15454230]
|
|
SH-SY5Y
|
IC50 |
24.19 1
Compound: 4; FL118
|
Antiproliferative activity against human SH-SY5Y cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human SH-SY5Y cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
HepG2
|
IC50 |
10.64 1
Compound: 4; FL118
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
SW-620
|
IC50 |
0.93 1
Compound: 4; FL118
|
Antiproliferative activity against human SW-620 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human SW-620 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NCI-H69
|
IC50 |
15.81 1
Compound: 4; FL118
|
Antiproliferative activity against human NCI-H69 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human NCI-H69 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
U-87MG ATCC
|
IC50 |
108.57 1
Compound: 4; FL118
|
Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NCI-H446
|
IC50 |
18.54 1
Compound: 4; FL118
|
Antiproliferative activity against Irinotecan-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against Irinotecan-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
HL-60
|
IC50 |
|
Inhibition of Topoisomerase I by cleavage complex formation in human HL-60 cells
Inhibition of Topoisomerase I by cleavage complex formation in human HL-60 cells
|
[PMID: 8410981]
|
|
Bel-7402
|
IC50 |
21.75 1
Compound: 4; FL118
|
Antiproliferative activity against human Bel-7402 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human Bel-7402 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
H69AR
|
IC50 |
6.29 1
Compound: 4; FL118
|
Antiproliferative activity against human NCI-H69AR cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human NCI-H69AR cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
HCT-116
|
IC50 |
|
Growth inhibition of human HCT-116 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
Growth inhibition of human HCT-116 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
|
[PMID: 38100041]
|
|
SH-SY5Y
|
IC50 |
24.19 1
Compound: 4; FL118
|
Antiproliferative activity against human SH-SY5Y cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human SH-SY5Y cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
MCF7
|
IC50 |
|
Growth inhibition of human MCF7 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
Growth inhibition of human MCF7 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
|
[PMID: 38100041]
|
|
HeLa
|
IC50 |
|
Growth inhibition of human HeLa cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
Growth inhibition of human HeLa cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
|
[PMID: 38100041]
|
|
2008
|
IC50 |
37.28 1
Compound: 4; FL118
|
Antiproliferative activity against human 2008 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human 2008 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
HepG2
|
IC50 |
|
Growth inhibition of human HepG2 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
Growth inhibition of human HepG2 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
|
[PMID: 38100041]
|
|
HCT-116
|
EC50 |
0.36 1
Compound: 11; FL118
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell viability measured after 72 hrs by MTT assay
|
[PMID: 38421819]
|
|
A549
|
IC50 |
|
Growth inhibition of human A549 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
Growth inhibition of human A549 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
|
[PMID: 38100041]
|
|
HCT-116
|
IC50 |
0.005 3
Compound: 3; FL118
|
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as reduction in cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 38092421]
|
|
MCF7
|
IC50 |
63.26 1
Compound: 4; FL118
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
HCT-116
|
IC50 |
|
Growth inhibition of human HCT-116 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
Growth inhibition of human HCT-116 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
|
[PMID: 38100041]
|
|
U-87MG ATCC
|
IC50 |
108.57 1
Compound: 4; FL118
|
Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
HCT-116
|
IC50 |
50 14
Compound: 11; FL118
|
Cytotoxicity against human HCT-116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human HCT-116 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 38421819]
|
|
HCT-8
|
IC50 |
0.005 3
Compound: 3; FL118
|
Antiproliferative activity against human HCT-8 cells assessed as inhibition of cell growth
Antiproliferative activity against human HCT-8 cells assessed as inhibition of cell growth
|
[PMID: 38092421]
|
|
NCI-H460
|
IC50 |
0.003 3
Compound: 3; FL118
|
Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
|
[PMID: 38092421]
|
|
HL-60
|
IC50 |
|
Inhibition of Topoisomerase I by cleavage complex formation in human HL-60 cells
Inhibition of Topoisomerase I by cleavage complex formation in human HL-60 cells
|
[PMID: 8410981]
|
|
SW-620
|
IC50 |
0.009 3
Compound: 3; FL118
|
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38092421]
|
|
HeLa
|
IC50 |
|
Growth inhibition of human HeLa cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
Growth inhibition of human HeLa cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
|
[PMID: 38100041]
|
|
HeLa
|
IC50 |
40 14
Compound: 11; FL118
|
Cytotoxicity against human HeLa cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human HeLa cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 38421819]
|
|
HeLa
|
IC50 |
9.6 1
Compound: Methylenedioxy Camptothecin (table 1)
|
Concentration required to inhibit growth of human cervical HeLa carcinoma cell line
Concentration required to inhibit growth of human cervical HeLa carcinoma cell line
|
[PMID: 15454230]
|
|
HepG2
|
IC50 |
10.64 1
Compound: 4; FL118
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
HepG2
|
IC50 |
104 14
Compound: 11; FL118
|
Cytotoxicity against human HepG2 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as reduction in cell growth incubated for 72 hrs by MTT assay
|
[PMID: 38421819]
|
|
HepG2
|
IC50 |
|
Growth inhibition of human HepG2 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
Growth inhibition of human HepG2 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
|
[PMID: 38100041]
|
|
MCF7
|
IC50 |
|
Growth inhibition of human MCF7 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
Growth inhibition of human MCF7 cells incubated for 48 hrs by MTT reagent based ELISA reader analysis
|
[PMID: 38100041]
|
|
MCF7
|
IC50 |
63.26 1
Compound: 4; FL118
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NCI-H446
|
IC50 |
18.54 1
Compound: 4; FL118
|
Antiproliferative activity against Irinotecan-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against Irinotecan-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NCI-H446
|
IC50 |
6.61 1
Compound: 4; FL118
|
Antiproliferative activity against etoposide/cisplatin combination-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against etoposide/cisplatin combination-resistant human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NCI-H446
|
IC50 |
8.87 1
Compound: 4; FL118
|
Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human NCI-H446 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NCI-H460
|
IC50 |
0.003 3
Compound: 3; FL118
|
Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell viability incubated for 24 hrs by MTT assay
|
[PMID: 38092421]
|
|
NCI-H69
|
IC50 |
15.81 1
Compound: 4; FL118
|
Antiproliferative activity against human NCI-H69 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human NCI-H69 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
NSCLC
|
EC50 |
1 1
Compound: 24; FL118, Table 2, cpd 7
|
Cytotoxicity against human NSCLC cells
Cytotoxicity against human NSCLC cells
|
[PMID: 34175539]
|
|
PC-3
|
IC50 |
8.1 1
Compound: Methylenedioxy Camptothecin (table 1)
|
Concentration required to inhibit growth of human prostate PC-3 carcinoma cell line
Concentration required to inhibit growth of human prostate PC-3 carcinoma cell line
|
[PMID: 15454230]
|
|
SH-SY5Y
|
IC50 |
24.19 1
Compound: 4; FL118
|
Antiproliferative activity against human SH-SY5Y cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human SH-SY5Y cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
SW-620
|
IC50 |
0.009 3
Compound: 3; FL118
|
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human SW620 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38092421]
|
|
SW-620
|
IC50 |
0.93 1
Compound: 4; FL118
|
Antiproliferative activity against human SW-620 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human SW-620 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|
|
U-87MG ATCC
|
IC50 |
108.57 1
Compound: 4; FL118
|
Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
Antiproliferative activity against human U87 cells assessed as inhibition of cell growth incubated for 72 hrs by SRB assay
|
[PMID: 35932565]
|